Ahmedabad: Zydus Lifesciences Limited has announced the completion of the acquisition of an 85.6 percent stake in Amplitude ...

Amplitude Surgical company has requested Euronext to suspend the listing of its shares (ISIN: FR0012789667, Ticker: AMPLI, eligible PEA-PME) on Euronext market with effect as from the publication of ...

Amplitude Surgical’s direct business (French market and international subsidiaries), which accounted for almost 92% of the Group’s total sales, generated growth of 4.5% at constant exchange rates.

Amplitude Surgical - 9-Months Consolidated Sales for FY 2024-25 of €83.8m, up +6.4% at Constant Exchange Rates Provided by Business Wire Apr 17, 2025 9:00am ...

Over the 1st half (July - December) of the 2024-25 financial year, Amplitude Surgical's sales totaled €51.5 million, up +5.0% and +6.3% at constant exchange rates on the previous year. Amplitude ...

About Amplitude Surgical Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics.

Amplitude Surgical sent the AMF, also on December 7, 2020, its draft response to the Auroralux simplified public tender offer for the Company’s shares at €2.15 per share.

Amplitude provides surgical technologies for lower limb orthopedics Zydus Lifesciences is the buyer The deal is valued at a price of €6.25 per share PAI Partners has entered exclusive talks to ...

VALENCE, France, April 17, 2025--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, ...

VALENCE, France, April 17, 2025--Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, ...